Metropolitan Life Insurance Company (MetLife)’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-177,221
Closed -$37.7M 2682
2014
Q4
$37.7M Sell
177,221
-249
-0.1% -$49.5K 0.26% 76
2014
Q3
$31.6M Sell
177,470
-3,069
-2% -$510K 0.23% 92
2014
Q2
$30.6M Sell
180,539
-8,786
-5% -$1.37M 0.21% 96
2014
Q1
$23.5M Sell
189,325
-2,171
-1% -$264K 0.16% 123
2013
Q4
$21.3M Sell
191,496
-5,116
-3% -$489K 0.15% 137
2013
Q3
$17.8M Sell
196,612
-1,312
-0.7% -$118K 0.14% 149
2013
Q2
$16.7M Buy
+197,924
New +$20.5M 0.13% 146

Other funds holding AGN

Metropolitan Life Insurance Company (MetLife)'s AGN Position: Q1 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 177,221 shares — an estimated $37.7M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $37.7M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 177,221 Allergan Inc shares in Q1 2015, an estimated $37.7M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Allergan Inc position peaked at $37.7M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2015, filed 15 May 2015.